Michinori Tanaka

Anti-neovascular therapy using novel peptides homing to angiogenic vessels

Naoto Oku, Tomohiro Asai, Koh Watanabe et al. · Oncogene · 2002 · 119 citations

Angiogenesis, Cardiovascular Disease, Novel Peptides +5

7-Chloro-5-hydroxy-1-[2-methyl-4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-1-benzazepine (OPC-41061): A potent, orally active nonpeptide arginine vasopressin V2 receptor antagonist

Kazumi Kondo, Hidenori Ogawa, Hiroshi Yamashita et al. · Bioorganic & Medicinal Chemistry · 1999 · 113 citations · Full text

Orally Active, Nonpeptide Vasopressin V₂ Receptor Antagonists:  A Novel Series of 1-[4-(Benzoylamino)benzoyl]-2,3,4,5-tetrahydro-1<i>H</i>-benzazepines and Related Compounds

Hidenori Ogawa, Hiroshi Yamashita, Kazumi Kondo et al. · Journal of Medicinal Chemistry · 1996 · 84 citations · Full text

Terminal Benzoyl Ring, Molecular Pharmacology, Medicinal Chemistry +13

Ionization and Fragmentation of Some Chlorinated Compounds and Dibenzo-<i>p</i>-dioxin with an Intense Femtosecond Laser Pulse at 800 nm

Hideo Harada, Michinori Tanaka, Masanao Murakami et al. · The Journal of Physical Chemistry A · 2003 · 58 citations

Engineering, Laser Science, Organic Hydrocarbons +20

Design of a Novel HIV-1 Fusion Inhibitor That Displays a Minimal Interface for Binding Affinity

Shinya Oishi, Saori Ito, Hiroki Nishikawa et al. · Journal of Medicinal Chemistry · 2008 · 50 citations